Model
Edge
Nabriva Therapeutics
0001732196
Filing Type
3
Filing Date
6/3/2021
Updated
6/4/21, 11:48 AM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership